Literature DB >> 10450271

Differential effect of number of previous episodes of affective disorder on response to lithium or divalproex in acute mania.

A C Swann1, C L Bowden, J R Calabrese, S C Dilsaver, D D Morris.   

Abstract

OBJECTIVE: The authors investigated the relationship between number of lifetime episodes of affective disorder and the antimanic response to lithium, divalproex, or placebo.
METHOD: The subjects were 154 of the 179 inpatients with acute mania who entered a 3-week parallel group, double-blind study. The primary efficacy measure was the manic syndrome score from the Schedule for Affective Disorders and Schizophrenia. The relationship between improvement and number of previous episodes was investigated by using nonlinear regression analysis.
RESULTS: An apparent transition in the relationship between number of previous episodes and response to antimanic medication occurred at about 10 previous episodes. For patients who had experienced more episodes, response to lithium resembled the response to placebo but was worse than response to divalproex. For patients who had experienced fewer episodes, however, the responses to lithium and divalproex did not differ and were better than the response to placebo. This differential response pattern was not related to rapid cycling or mixed states.
CONCLUSIONS: A history of many previous episodes was associated with poor response to lithium or placebo but not to divalproex.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10450271     DOI: 10.1176/ajp.156.8.1264

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN: 0002-953X            Impact factor:   18.112


  40 in total

Review 1.  Staging bipolar disorder.

Authors:  Eduard Vieta; M Reinares; A R Rosa
Journal:  Neurotox Res       Date:  2010-05-12       Impact factor: 3.911

2.  Commentary on N. Ghaemi's "Hippocratic Psychopharmacology of Bipolar Disorder" Treating Bipolar Disorder: For the Patient or Against the Illness?

Authors:  Alan C Swann
Journal:  Psychiatry (Edgmont)       Date:  2006-06

Review 3.  Stage managing bipolar disorder.

Authors:  Michael Berk; Lesley Berk; Seetal Dodd; Sue Cotton; Craig Macneil; Rothanthi Daglas; Philippe Conus; Andreas Bechdolf; Steven Moylan; Gin S Malhi
Journal:  Bipolar Disord       Date:  2013-06-20       Impact factor: 6.744

4.  Changes in the corpus callosum in women with late-stage bipolar disorder.

Authors:  L Lavagnino; B Cao; B Mwangi; M-J Wu; M Sanches; G B Zunta-Soares; F Kapczinski; J Soares
Journal:  Acta Psychiatr Scand       Date:  2015-01-31       Impact factor: 6.392

5.  3-Nitrotyrosine and glutathione antioxidant system in patients in the early and late stages of bipolar disorder.

Authors:  Ana Cristina Andreazza; Flavio Kapczinski; Marcia Kauer-Sant'Anna; Julio C Walz; David J Bond; Carlos A Gonçalves; L Trevor Young; Lakshmi N Yatham
Journal:  J Psychiatry Neurosci       Date:  2009-07       Impact factor: 6.186

Review 6.  Staging and neuroprogression in bipolar disorder.

Authors:  Gabriel Rodrigo Fries; Bianca Pfaffenseller; Laura Stertz; André Vinicius Contri Paz; Aroldo Ayub Dargél; Maurício Kunz; Flávio Kapczinski
Journal:  Curr Psychiatry Rep       Date:  2012-12       Impact factor: 5.285

7.  Staging in bipolar disorder: from theoretical framework to clinical utility.

Authors:  Michael Berk; Robert Post; Aswin Ratheesh; Emma Gliddon; Ajeet Singh; Eduard Vieta; Andre F Carvalho; Melanie M Ashton; Lesley Berk; Susan M Cotton; Patrick D McGorry; Brisa S Fernandes; Lakshmi N Yatham; Seetal Dodd
Journal:  World Psychiatry       Date:  2017-10       Impact factor: 49.548

8.  The pharmacogenetics of lithium response depends upon clinical co-morbidity.

Authors:  Troy Bremer; Cornelius Diamond; Rebecca McKinney; Tatyana Shehktman; Thomas B Barrett; Chris Herold; John R Kelsoe
Journal:  Mol Diagn Ther       Date:  2007       Impact factor: 4.074

9.  Undiagnosed Bipolar Disorder: New Syndromes and New Treatments.

Authors:  Ira D Glick
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2004

Review 10.  Mood disorders and substance use disorder: a complex comorbidity.

Authors:  Susan B Quello; Kathleen T Brady; Susan C Sonne
Journal:  Sci Pract Perspect       Date:  2005-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.